Voya Financial's growth could come from recent business acquisitions, new client money inflows, and health plan sales. Read ...

On February 27, 2025, we announced the results from 2024 and early-2025 drilling at Grey Fox expanding the Gibson Zone. Along with the discovery of multiple gold lenses, drill assays returned good ...

On 3 April 2024, the Company announced publication of the results of the RED DESERT and SAHARA proof-of-concept studies, in the prestigious peer-reviewed journal European Journal of Heart Failure.

Sequana Medical announces 2024 Full Year Results and 2025 Outlook alfapump® - US FDA approval of alfapump® for the treatment of recurrent or refractory ascites due to liver cirrhosis; US commercial ...